Omar Chaabo

IC Mcgill / University Of Texas MB AHFTC Houston Methodist AUBMC, weill cornell medical college HMC, AΩA Medical Honors society , lifelong learner.

[Journal of Invasive Cardiology @InvasiveCardiol]

From the April issue: Coring Aspiration Thrombectomy or “CAT Pounce” Technique for Large Coronary Thrombi Resistant to Aspiration Alone ➡️
https://t.co/aD9A5fNso7

@HadyLichaaMD @DLBHATTMD #cardioTwitter #cardioX #cardiology #interventionalcardiology

[Heart_BMJ @Heart_BMJ]

Percutaneous ventricular assist devices in high-risk PCI for older adults: evidence and next steps https://t.co/cUnGsddPkD

[WilliamZoghbi @WilliamZoghbi]

Hot off the press! My Editorial in JACC on Atrial functional MR. Among 72 definitions of AfMR (!!) in the literature, Koschatko et al demonstrated that the one provided by JACC CV Imaging Expert Panel in 2022 was the most powerful in predicting outcome. https://t.co/9lOYA0x3Ak

[JACC Journals @JACCJournals]

The RETRY protocol for radial artery occlusion recanalization, based on ultrasound-guided distal radial access and DCB angioplasty, is feasible, safe, and associated with excellent technical success and favorable short-term patency. https://t.co/EzP2NstK7F

[EuroIntervention @EuroInterventio]

Lesion stratification with intracoronary imaging provides detailed morphological insights that may guide PCI, identify high-risk plaques, and support a shift towards integrated morphofunctional assessment in coronary artery disease.

https://t.co/Bc6jp82gE1

@m_g_mcgarvey @K_DeSilva @DrKeeble @ziadalinyc @divaka_perera @drdworakowski @DrNileshPareek

#CardioTwitter #InterventionalCardiology #CoronaryArteryDisease

[Eric Topol @EricTopol]

A good, new review of orthostatic hypotension, POTS @JAMAInternalMed https://t.co/hKCdwtOFIY

[JACC Journals @JACCJournals]

Decades of research show CAC as an accurate, cost-effective test to detect subclinical CAD. This #JACCIMG consensus from Drs. Naghavi, Fuster, et al calls on CMS to recognize CAC as a diagnostic test essential to personalized prevention. https://t.co/pqeZAnEMw9 #cvCAD #ASCVD

[NEJM @NEJM]

Presented at #SVIN25:

CREST-2: In high-grade asymptomatic carotid stenosis, addition of stenting to medical therapy led to a lower risk of stroke over a 4-year period. Endarterectomy did not lead to a significant benefit. Full results: https://t.co/ojge1CjqiU

Editorial: Managing Asymptomatic Carotid Stenosis https://t.co/D9LH89Edyk

@svinsociety

[American College of Cardiology @ACCinTouch]

In pts w/ #cvACS undergoing #PCI, the benefits of shortening DAPT vary based on monotherapy, w/ P2Y12 inhibitor monotherapy "significantly reducing" net adverse clinical events & major bleeding, whereas aspirin monotherapy had "neutral results". https://t.co/zi6p83llOL #JACCINT

[Houston Methodist @MethodistHosp]

We’re both honored and excited to announce that Houston Methodist Hospital has been named The Best Hospital in Texas for 14 years in a row by @USNews. We’re proud to be a top-ranked hospital in the country, and nationally ranked in 10 specialties.

[Houston Methodist CV @HMethodistCV]

Each year, @USNews publishes a list of the top ranked hospitals in the U.S. This year, we’re both honored and excited that Houston Methodist Hospital is ranked No. 14 in Cardiology & Heart Surgery in the nation.

[Houston Methodist MD @HMethodistMD]

@usnews @eamonnquigleymd @KKseattle @pedroramirezMD Each year, @USNews publishes a list of the top ranked hospitals in the United States. This year, we’re both honored and excited that Houston Methodist Hospital tied for No. 8 in Pulmonology & Lung Surgery in the nation.

[Houston Methodist MD @HMethodistMD]

We’re both honored and excited to announce that Houston Methodist Hospital has been named The Best Hospital in Texas for 14 years in a row by @USNews. We are proud to be a top ranked hospital in the nation, and nationally ranked in 10 specialties.

[Michael Megaly @MichaelMegalyMD]

It was a great pleasure to be a part of @cvinnovations #CVI2025, learned a lot as usual and came back with multiple tips and tricks.

Here are my top ones that I would apply in my next cases.

1- When freewiring the Rotawire in uncrossable lesions, a nice trick shared by @KateKearney4 is to use Finecross specifically as it centers you more within the lesion.
I used whatever microcatheter I usually use (mostly TP spiral).

2- When doing laser bombing with contrast, can use 20/80 mix to create smaller bubbles and less risk of perforation.
I used the 100% contrast when I did it, and looking forward to trying this trick!

3- When using high-pressure #OPN balloons, having a buddy wire is very helpful. It can help with scoring effect, maintain wire position if the balloon got stuck on the wire, and provides rapid access in case of perforation.

4-When the distal IVC is affected in chronic venous disease, avoid double-barrel venous stenting. Outcomes are better with an IVC stent with 2 extending limbs from both iliac veins. Looking forward to next year!

@esbrilakis @Xlpad @shishem @psorajja
#CardioX

[Muthu Vaduganathan @mvaduganathan]

Just 5 years ago, HFpEF was described as the “stepchild” of HF with no approved therapies.

Today, there are 5 US FDA therapies:
✅ Empagliflozin (#EMPEROR)
✅ Dapagliflozin (#DELIVER)
✅ Sotagliflozin (#SOLOISTWHF)
✅ Sacubitril/Valsartan (#PARAGONHF)
✅ Finerenone (#FINEARTSHF)

[Journal of Invasive Cardiology @InvasiveCardiol]

April Review: Update on the Diagnosis and Treatment of Coronary Complications of Percutaneous Coronary Interventions ➡️
https://t.co/ieSMFAtR5N
@sant_j_kumar @esbrilakis @DLBHATTMD #cardioTwitter #cardioX #cardiology #interventionalcardiology

[Jeff Teuteberg @JeffTeuteberg]

👀Data on almost 1500 DCD 🫀transplants compared to DBD from @ISHLT registry by @rcogswell_umn at #ISHLT2025. No difference in 1️⃣ year survival‼️
@TheJHLT @preventfailure

[JACC Journals @JACCJournals]

#JACCIMG state-of-the-art review: How has our understanding of cardiac #amyloidosis changed in the past decade? 🤔

Get the details here: https://t.co/Swc0apKZkx

#cvImaging #CardioOnc #CardioX @DorbalaSharmila @MicheleEmdin @SinghVasvi

[JACC Journals @JACCJournals]

#EHRA2025 #JACCINT LBCT: In this large nationwide registry, patients receiving pacemaker implantation within 30 days after #TAVR had significantly higher rates of overall and cardiovascular mortality up to 10 years. https://t.co/XPi9ti2HbV #SwissTAVI

[CircInterventions @CircIntv]

Is one drug better than another? A randomized comparison of sirolimus-coated balloon versus paclitaxel-coated balloon for the treatment of in-stent restenosis #cardiotwitter #AHAJournals https://t.co/xXALEnx35Z